Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG42776

CBX5 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

CBX5 Knockout HAP1 Polyclonal Cells offer a CRISPR/Cas9-edited polyclonal knockout population for studying the heterochromatin protein HP1?? in a haploid human cell model. Derived from KBM-7, HAP1 cells provide a robust genetic background with single-allele disruption yielding complete loss-of-function. CBX5 (HP1??) binds H3K9me3 and interacts with SUV39H1, HDAC1, and lamin B receptor to enforce gene silencing and chromatin compaction. This model is ideal for research on epigenetic silencing, DNA repair, and cancer biology, and supports assays such as ChIP-qPCR, RNA-seq, and DNA damage analysis.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    CBX5

    Gene Identifier

    NCBI Gene ID 23468

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

CBX5 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population for loss-of-function studies of CBX5 (HP1??) in a haploid human model. This heterogeneous edited pool provides robust target-gene disruption, avoiding clonal bias and enabling consistent phenotypic analysis. The polyclonal format is ideal for high-throughput screening and diverse molecular assays.

The HAP1 cell line, derived from KBM-7 chronic myeloid leukemia cells, is a near-haploid human model valued for genetic studies. Its haploid karyotype simplifies knockout interpretation, as a single disrupted allele often yields complete loss of function. With rapid growth and maintained signaling pathways, HAP1 cells are widely used in research on cell cycle, DNA repair, and epigenetic regulation.

CBX5 (HP1??) is a heterochromatin protein that binds H3K9me3 marks deposited by SUV39H1. It recruits HDAC1, DNMT1, and lamin B receptor to promote transcriptional repression and chromatin compaction. Upstream regulators include E2F1, TP53, RB1, Aurora B, and CDK1. CBX5 interacts with SUV39H1, CHAF1A, TIF1??, and BRG1 to propagate silencing and maintain genome architecture. Downstream, it represses CDKN1A (p21), linking heterochromatin to cell cycle and DNA repair.

In HAP1 cells, CBX5 knockout disrupts constitutive heterochromatin, causing derepression of silenced genes, altered nuclear organization, and increased genome instability. This recapitulates epigenetic dysregulation observed in breast, prostate, and glioblastoma cancers, as well as aging-related heterochromatin loss. The haploid background allows clear dissection of HP1????s role in DNA damage repair and cell cycle checkpoint control, making it a valuable model for epigenetic drug target validation.

Typical applications include ChIP-qPCR for H3K9me3 profiling, RNA-seq for transcriptome analysis, and immunofluorescence or western blotting to monitor HP1?? expression and localization. DNA damage response can be assessed by ??H2AX foci quantification, and flow cytometry enables detailed cell cycle analysis. The polyclonal knockout population is suitable for investigating heterochromatin organization, epigenetic silencing, and development of cancer epigenetic therapies. For further details, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)